Cardinal Health

presented by
presented by
presented by
Health IT

12 healthcare industry trends driving Cardinal Health’s investment and innovation strategy

In the past few years, pharmaceutical distributor Cardinal Health (NYSE:CAH) has acquired a major distributor and half a dozen pharmaceutical companies in China. It also acquired AssuraMed to enter the home-health supply market, and invested in startups including HealthSpot, which makes a telemedicine kiosk, and Intralign, which helps providers optimize the cost and quality of […]

Pharma

Cardinal Health, Eli Lilly collaborate on Alzheimer’s imaging agent

Cardinal Health (NYSE:CAH) will manufacture and distribute a radioactive imaging agent from Eli Lilly (NYSE:LLY) that could help doctors diagnose Alzheimer’s disease. The imaging agent, called Amyvid, is scheduled for commercial launch on June 1, according to a statement from Dublin, Ohio-based Cardinal. Amyvid was approved by the U.S. Food and Drug Administration in April. […]

Pharma

New decision-support tool to help doctors follow cancer, arthritis best practices

New decision support technology from Cardinal Health (NYSE:CAH) is designed to help physicians follow cancer and rheumatoid arthritis “clinical pathways” — evidence-based treatment regimens. The new technology, called PathWare Solutions, would be purchased by a health insurance plan or payer, which would then make it available to physicians in its network, according to a spokeswoman […]

Devices & Diagnostics

Cardinal Health to buy drug distributor Dik Drug

Consolidation in the U.S. drug distribution business continues as Cardinal Health (NYSE:CAH) has purchased a Chicago-area regional drug wholesaler, Dik Drug Company. The acquisition was first reported by Adam Fein at Drug Channels and confirmed to MedCity News in a statement from a Cardinal spokeswoman. Dublin, Ohio-based Cardinal said it signed a definitive agreement to […]